期刊文献+

新生儿高胆红素血症与心肌损害的关系探讨 被引量:4

Relationship of neonatal hyperbilirubinemia and myocardial injury
下载PDF
导出
摘要 目的了解新生儿高胆红素血症对心功能的影响。方法对154例高胆红素血症和40非高胆红素血症的新生儿进行血胆红素、心肌肌钙蛋白Ⅰ(cTnⅠ)、肌酸激酶同功酶(CK-MB)测定。结果轻度组发病期和恢复期与对照组CK-MB差异均无统计学意义(均>0.05);轻度组恢复期cTnI与对照组差异无统计学意义(>0.05),发病期差异有统计学意义(<0.05)。中度组发病期CK-MB与cTnI与对照组差异均有统计学意义(均<0.05);恢复期CK-MB与cTnI与对照组差异均无统计学意义(均>0.05)。重度组发病期CK-MB与cTnI与对照组差异均有统计学意义(均<0.05);恢复期CK-MB与cTnI与对照组差异均无统计学意义(均>0.05)。结论高胆红素对新生儿心肌功能有暂时性损害。联合测定cTnⅠ、CK-MB水平可以监测高胆红素血症新生儿的心功能变化。 Objective To study the effect of neonatal hyperbilirubinemia on cardiac function.Methods One hundred and fifty-four neonates with hyperbilirubinemia were chosen as study group and 40 neonates with unhyperbilirubinemia were chosen and taken as control group.Serum urea bilirubin,cardiac troponin Ⅰand creatine kinase isoenzyme in both groups were determined.Results There was no significant difference in CK-MB of mild group and the control group(P〈0.05).There was no significant difference in cTnI of mild group recovery phase and the control group(P〈0.05),but there was a significant difference at onset phase(P〈0.05).As for CK-MB and cTnI,the moderate group at onset phase was significantly different with the control group(P〈0.05);but there was no significant difference at the recovery phase(P〈0.05).There were significant differences in CK-MB and cTnI between the control group and severe group atthe onset phase(P〈0.05,) but there were no significant difference in CK-MB and cTnI between the control group and severe group at the recovery phase(P〈0.05.) Conclusions The high bilirubin of newborn has temporary damage to myocardial func-tion.Measurement of cTnⅠ and CK-MB content can monitor high-biliary changes in myocardial function of newborns.
出处 《现代实用医学》 2011年第10期1091-1093,共3页 Modern Practical Medicine
基金 浙江省温州市科技局科学基金资助项目(Y20090423)
关键词 新生儿 高胆红素血症 心肌肌钙蛋白Ⅰ 肌酸激酶同功酶 Newborns Hyperbilirubinemia Cardiac troponin Ⅰ Creatine kinase isoenzyme
  • 相关文献

参考文献7

二级参考文献14

  • 1胡亚美 江载芳 诸福棠.实用儿科学(第7版)[M].北京:人民卫生出版社,2003..
  • 2王慕逖 主编.儿科学:第5版[M].,2001.97.
  • 3Burnett, M.S,Lee, C.W,Kinnaird, T.D,Stabile, E.,Durrani, S,Dullum, M.K,Devaney, J.M,Fishman, C,Stamou, S,Canos, D. et al.The potential role of resistin in atherogenesis[].Atherosclerosis.2005
  • 4Fan, H.Q,Gu, N,Liu, F,Pan, X.Q,Guo, M,Chen, R.H,Guo, X.R.Prolonged exposure to resistin inhibits glucose uptake in rat skeletal muscles[].Acta Pharmacol Sin.2007
  • 5Hotamisligil, G.S,Spiegelman, B.M.Tumor necrosisfactor alpha: a key component of the obesity-diabetes link[].Diabetes.1994
  • 6Kawanami, D,Maemura, K,Takeda, N,Harada, T,Nojiri, T,Imai, Y,Manabe, I,Utsunomiya, K,Nagai, R.Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocyto-kine-endothelial cell interactions[].Biochem Biophys Res Commun.2004
  • 7Kunnari, A,Ukkola, O,Paivansalo, M,Kesaniemi, Y.A.High plasma resistin level is associated with en-hanced highly sensitive C-reactive protein and leukocytes[].J Clin Endocrinal Metab.2006
  • 8Lubos, E,Messow, C,Schnabel, R,Rupprecht, H,Espinola-Klein, C,Bickel, C,Peetz, D,Post, F,Lackner, K,Tiret, L.Resistin, acute coronary syndrome and prognosis results from the AtheroGene study[].Athero- sclerosis.2007
  • 9Lyon, C.J,Law, R.E,Hsueh, W.A.Minireview: adi-posity, inflammation, and atherogenesis[].Endocrinology.2003
  • 10Matsuzawa, Y,Funahashi, T,Nakamura, T.Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocytederived bioactive substances[].Ann N Y Acad Sci.1999

共引文献830

同被引文献36

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部